Latest News
|
More Articles...
- Milestone Pharmaceuticals Announces Submission of New Drug Application to the U.S. FDA for Etripamil
- New Biosense Webster QDOT MICRO™ Catheter Data Demonstrate Very High-Power, Short-Duration Ablations Improved Quality of Life and Reduced Healthcare Utilization for AFib Patients
- Pulsecare Medical’s nsPFA Clinical Trial Receives Satisfactory Short-term Follow-up Results
- Yiling Pharmaceutical’s Shensong Yangxin Capsules Have Obtained Registration in Nigeria—Study Has Shown that It Significantly Improves the Prognosis of Patients After Radiofrequency Ablation
- Cadrenal Therapeutics Highlights Additional Need for a New Vitamin K Antagonist (Tecarfarin) Following Updates from the Recent European Society of Cardiology Congress
- Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial, Starting the Process For Bringing Ultra-Low-Temperature Cryoablation for Ventricular Arrhythmias to US Market
- BIOTRONIK, INC. Announces First US Implant of Next-Generation Amvia Edge Pacemaker
- Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device
- Endotronix Extends Positive Outcomes with 12-month Data Release from the SIRONA 2 Trial for Remote Heart Failure Management Using the Cordella Pulmonary Artery Sensor
- European Study Finds the Abbott CardioMEMS Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations
|
|